Healthcare ❯ Pharmaceuticals ❯ Drug Pricing ❯ Generic Drugs

Supply Chain Issues

U.S.–India Trade Rift Deepens as 50% U.S. Tariffs Bite and Trump Claims ‘No‑Tariff’ Offer

Court scrutiny now shapes the next phase of the tariff fight.